Type 2 diabetes and its associated comorbidities are growing more prevalent, and the
complexity of optimising glycaemic control is increasing, especially on the frontlines of …

The aim of this systematic review was to analyse whether there is an association between
severe hypoglycaemia and the incidence of dementia in patients with type 2 diabetes …

Background Oral semaglutide is the first oral glucagon-like peptide-1 (GLP-1) receptor
agonist for glycaemic control in patients with type 2 diabetes. Type 2 diabetes is commonly …

Guidelines RSSDI-ESI Clinical Practice Recommendations for the Management of Type 2
Diabetes Mellitus 2020Table. No title available.

Background: Nonalcoholic fatty liver disease (NAFLD) is emerging as a public health issue
worldwide and is highly prevalent in patients with type 2 diabetes mellitus (T2DM). However …

Aims To determine the global extent of hypoglycaemia experienced by patients with
diabetes using insulin, as there is a lack of data on the prevalence of hypoglycaemia in …

Background and aims Hypoglycemia represents a relevant burden in people with diabetes.
Consequences of hypoglycemia/fear of hypoglycemia on quality of life (QoL) and behaviors …

Sulphonylureas have been commercially available since the 1950s, but their use continues
to be associated with controversy. Although adverse cardiovascular outcomes in some …

IN BRIEF After assessing patient perspectives on the success of current diabetes therapies
and the factors that have the greatest impact on daily life, we show that time-in-range is a …

Objective Very few real-world studies have been conducted to assess the incidence of
diabetes-related hypoglycemia. Moreover, there is a paucity of studies that have …